ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,280.05
0.42%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Evoke Pharma Inc (EVOK)

  7. Evoke Pharma Inc (EVOK) News

Evoke Pharma (EVOK)

Evoke Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EVOK
DateTimeSourceHeadlineSymbolCompany
07/06/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
30/05/202423:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EVOKEvoke Pharma Inc
24/05/202422:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EVOKEvoke Pharma Inc
24/05/202421:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EVOKEvoke Pharma Inc
24/05/202421:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EVOKEvoke Pharma Inc
16/05/202421:02GlobeNewswire Inc.Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) ConferenceNASDAQ:EVOKEvoke Pharma Inc
14/05/202421:58Edgar (US Regulatory)Form ARS/A - Annual Report to Security Holders: [Amend]NASDAQ:EVOKEvoke Pharma Inc
14/05/202421:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EVOKEvoke Pharma Inc
14/05/202421:15GlobeNewswire Inc.Evoke Pharma Reports First Quarter 2024 Financial ResultsNASDAQ:EVOKEvoke Pharma Inc
14/05/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
14/05/202421:05Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:EVOKEvoke Pharma Inc
14/05/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
17/04/202413:30GlobeNewswire Inc.Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 MedicationsNASDAQ:EVOKEvoke Pharma Inc
21/03/202420:15GlobeNewswire Inc.Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive OfficerNASDAQ:EVOKEvoke Pharma Inc
14/03/202420:05GlobeNewswire Inc.Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:EVOKEvoke Pharma Inc
07/03/202421:10GlobeNewswire Inc.Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024NASDAQ:EVOKEvoke Pharma Inc
23/02/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
20/02/202421:38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EVOKEvoke Pharma Inc
14/02/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
14/02/202412:30GlobeNewswire Inc.Evoke Pharma Announces Closing of $7.5 Million Public OfferingNASDAQ:EVOKEvoke Pharma Inc
09/02/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
09/02/202422:14Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:EVOKEvoke Pharma Inc
09/02/202412:30GlobeNewswire Inc.Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 MillionNASDAQ:EVOKEvoke Pharma Inc
09/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EVOKEvoke Pharma Inc
08/02/202411:50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
11/01/202402:38Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
04/01/202421:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
19/12/202313:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
15/12/202321:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
29/11/202314:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:EVOK

Your Recent History

LSE
PANR
Pantheon Resources
LSE
AAZ
Anglo Asian Mining
LSE
ENET
Ethernity Networks
LSE
SDRY
Superdry
LSE
INSG
Insig Ai
LSE
PHNX
Phoenix
LSE
HUM
Hummingbird Resources
LSE
BP.
Bp
LSE
AFC
Afc Energy
LSE
HE1
Helium One Global
LSE
GPM
Golden Prospect Precious...
LSE
JIM
Jarvis Securities
LSE
CUSN
Cornish Metals
LSE
SRSP
Sirius Petroleum
LSE
IES
Invinity Energy Systems
LSE
FUM
Futura Medical
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved